Davis Andrew S.'s Form 4 filing
Silk Road Medical Inc (SILK) · filed Apr 5, 2023
- Accession no.
- 0001209191-23-023399
- Filed
- Apr 5, 2023
- Trade date
- Apr 3, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $266.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Davis Andrew S.CIK 0001770191 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 3, 2023 | Common Stock | MOption exerciseAcquired | +312 | $6.11 | +$1,906.32 | 115,995 | Direct | |
| Apr 3, 2023 | Common Stock | MOption exerciseAcquired | +1,475 | $4.73 | +$6,976.75 | 117,470 | Direct | |
| Apr 3, 2023 | Common Stock | MOption exerciseAcquired | +4,966 | $4.73 | +$23,489.18 | 122,436 | Direct | |
| Apr 3, 2023 | Common Stock | SSaleDisposed | −312 | $39.42F2 | −$12,299.04 | 122,124 | Direct | |
| Apr 3, 2023 | Common Stock | SSaleDisposed | −1,475 | $39.42F2 | −$58,144.5 | 120,649 | Direct | |
| Apr 3, 2023 | Common Stock | SSaleDisposed | −4,966 | $39.42F2 | −$195,759.72 | 115,683 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 3, 2023 | Common Stock | MOption exerciseDisposed | −1,475 | $0.00 | $0 | 47,451 | Direct | |
| Apr 3, 2023 | Common Stock | MOption exerciseDisposed | −4,966 | $0.00 | $0 | 21,304 | Direct | |
| Apr 3, 2023 | Common Stock | MOption exerciseDisposed | −312 | $0.00 | $0 | 2,335 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at price ranging from $38.67 to $40.29. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.